🇺🇸 FDA
Patent

US 8252764

Compositions and methods of use of targeting peptides against placenta and adipose tissues

granted A61KA61K31/70A61K38/08

Quick answer

US patent 8252764 (Compositions and methods of use of targeting peptides against placenta and adipose tissues) held by The Board of Regents of the University of Texas System expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/70, A61K38/08, A61P, A61P3/04